NCT07686601Enrolling by invitation
Metabolic Effectiveness of Extracorporeal Shockwave on Abdominal Adiposity
Source: ClinicalTrials.gov · Last updated 7 Jul 2026
Brief summary (registry, in English)
Egyptian Ministry of Health and Population's Preventive Sector, have named obesity as one of the top contributors to the national mortality and morbidity. Abdominal obesity is a strong predictor of metabolic disorders and premature mortality. Visceral fat is metabolically active and sensitive for lipolysis, unless it is more insulin resistant. It is well-known that overweight and/ or obesity is associated with overactivated proinflammatory cytokines those overactivated inflammatory process thus led to organs dysfunction across persistent low-grade inflammations . Recently, extracorporeal shock wave represents a promising, non-invasive management strategy supporting the treatment of a variety of conditions related to plastic surgery. As well, it displayed a good safety profile with no serious adverse events . The need of this study develops from the lack in the quantitative knowledge and information regarding overall metabolic effectiveness of the Extracorporeal Shockwave on abdominal adiposity.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- First submitted
- 23 Jun 2026
- Start date
- 1 Jun 2026
- Primary completion date
- 1 Mar 2027
- Lead sponsor
- Cairo University
- Diseases
- Obesity
- NCT number
- NCT07686601
What you commit to
- Study type: Interventional
- Planned participants: 90
- From 1 Jun 2026 to the primary completion date, 1 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who received pharmacological drugs for controlling obesity were excluded.
Other illness
- Patients with diabetes mellitus, heart and/ or vascular, renal, hepatic, pulmonary, neurological, psychological, and or mental disorders are excluded.
- Patients who had autoimmune diseases were excluded.
- Patients with hypertension, metal or electronic implants were excluded.
- Patients who have cancer were excluded.
Other
- Patients who had the following features will be excluded from the study:
- Patients, who have intra-abdominal mesh and/ or unrepaired abdominal hernia were excluded.
- Patients who have scars, open lesions and wounds at treatment area were excluded.
- Patients who have any intervention to lose weight or body contouring within the last 6 months (diet, exercise or body contouring devices) were excluded.
Who the study is looking for
- This study will be delimited by:
- Age \> 18years old.
- All of them suffered from abdominal obesity.
- All have waist/ hip ratio of \> 0.85 and their waist circumference \> 90 cm.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shebin ElKom Teaching Hospital Coordinator of this site? Confirm its status | Shibīn al Kawm | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.